Sign in

CIK 0001730430 · Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981795578
Phone
7814319100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$78,588,440
in 8 filings, $78.6M under 10b5-1 plans

Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
  2. Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
  3. Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
  4. Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
  5. Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Date Insider Transaction Shares Price Value Owned after
2018-09-20 Heberlig Chris EVP & CFO Grant or award · Share Option +45,000 45,000
2018-09-20 Beetham Thomas W. EVP & Chief Legal Officer Grant or award · Share Option +45,000 45,000
2018-05-29 BAKER BROS. ADVISORS LP Director Purchase +299,403 $18.00 $5.4M 299,403
2018-05-29 BAKER BROS. ADVISORS LP Director Purchase +2,700,597 $18.00 $48.6M 2,700,597
2018-05-29 BAKER BROS. ADVISORS LP Director Conversion · Series C Preferred −420,897 0
2018-05-29 BAKER BROS. ADVISORS LP Director Conversion · Class A1 Common Shares +420,897 420,897
2018-05-29 BAKER BROS. ADVISORS LP Director Conversion · Series C Preferred −3,734,103 0
2018-05-29 BAKER BROS. ADVISORS LP Director Conversion · Class A1 Common Shares +3,734,103 3,734,103
2018-05-29 BAKER BROS. ADVISORS LP Director Conversion · Series B Preferred −313,621 0
2018-05-29 BAKER BROS. ADVISORS LP Director Conversion · Class A1 Common Shares +313,621 734,518
2018-05-29 BAKER BROS. ADVISORS LP Director Conversion · Series B Preferred −3,284,771 0
2018-05-29 BAKER BROS. ADVISORS LP Director Conversion · Class A1 Common Shares +3,284,771 7,018,874
2018-05-29 BAKER BROS. ADVISORS LP Director Conversion · Series A Preferred −1,399,516 0
2018-05-29 BAKER BROS. ADVISORS LP Director Conversion · Class B1 Common Shares +1,399,516 1,399,516
2018-05-29 BAKER BROS. ADVISORS LP Director Conversion · Series A Preferred −14,658,102 0
2018-05-29 BAKER BROS. ADVISORS LP Director Conversion · Class B1 Common Shares +14,658,102 14,658,102
2018-05-29 Flynn James E 10% owner Conversion +383,538 383,538
2018-05-29 Flynn James E 10% owner Purchase +333,333 $18.00 $6.0M 333,333
2018-05-29 Flynn James E 10% owner Purchase +250,000 $19.81 $5.0M 583,333
2018-05-29 Flynn James E 10% owner Purchase +25,000 $20.91 $523K 608,333

Page 78 of 80 · 1,595 trades